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Abstract
DNA methylation is a key epigenetic process which has been intimately associated with gene reg-
ulation. In recent years growing evidence has associated DNA methylation status with a variety
of diseases including cancer, Alzheimer’s disease and cardiovascular disease. Moreover, changes to
DNA methylation have also recently been implicated in the ageing process. The factors which
underpin DNA methylation are complex, and remain to be fully elucidated. Over the years math-
ematical modelling has helped to shed light on the dynamics of this important molecular system.
Although the existing models have contributed significantly to our overall understanding of DNA
methylation, they fall short of fully capturing the dynamics of this process. In this paper we develop
a linear and nonlinear model which captures more fully the dynamics of the key intracellular events
which characterise DNA methylation. In particular the outcomes of our linear model result in
gene promoter specific methylation levels which are more biologically plausible than those revealed
by previous mathematical models. In addition, our nonlinear model predicts DNA methylation
promoter bistability which is commonly observed experimentally. The findings from our models
have implications for our current understanding of how changes to the dynamics which underpin
DNA methylation affect ageing and health. We also propose how our ideas can be tested in the
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HIGHLIGHTS
• The linear model accounts for the overall epigenetic inheritance of DNA methylation patterns and
dynamics.
• The nonlinear model can predict the hypomethylated and hypermethylated states of gene promoters.
• DNA methylation dynamics do not alter when the quantity of DNA methylation enzymes changes.
1. Introduction
DNA methylation is considered a key epigenetic mark for mammalian gene expression and reg-
ulation (Smith and Meissner, 2013). Intriguingly, a growing body of experimental evidence suggests
age-related changes to the methylation status of the genome have a fundamental role to play in
healthspan (Jones et al., 2015). For instance, age-related DNA methylation changes are closely cor-5
related with cancer (Klutstein et al., 2016). Moreover, alterations to genomic methylation patterns
with age have an emerging role to play in many age-related pathologies including, Alzheimers disease
(De Jager et al., 2014), cardiovascular disease (Zhong et al., 2016) and osteoporosis/osteoarthritis
(Delgado-Calle et al., 2013). It has also been postulated that genomic methylation status could be
used to quantify intrinsic ageing by virtue of a methylation clock, where DNA methylation age is10
underscored by the cumulative effect of an epigenetic maintenance system (Horvath, 2013; Horvath
et al., 2016). Taken together these findings suggest that perturbations to the molecular reactions
which are responsible for preserving DNA methylation could significantly impact the trajectory of
healthspan and possibly ageing. In mammals these reactions occur primarily at CpG dyads, where
the methyl group is attached to the fifth carbon of the cytosine at the CpG site (Bird, 2002; Holli-15
day and Pugh, 1975; Riggs, 1975; Sager and Kitchin, 1975). A CpG site being a 5′ − 3′ Cytosine
- Guanine dinucleotide sequence within the DNA molecule with p indicating the phosphate group
between the two nucleotides. A dyad consists of two CpG sites, one on each strand of the DNA
molecule, while regions of DNA which contain a high frequency of CpG sites are referred to as
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CpG islands (CGIs). Such islands consist of approximately 500− 2000 mainly unmethylated base20
pairs which cover in the region of 1% of the mammalian genome (Jones and Liang, 2009).
Despite the sparseness of CGIs within the genome they are acutely important due to the as-
sociation their methylation status has with gene promoter activity. Specifically, hypermethylation,
of CGIs is routinely correlated with the transcriptional silencing of gene promoters, a phenomenon
which is often a feature of diseases such as cancer (Esteller et al., 2000; Kane et al., 1997). Moreover,25
advancing age has been associated with the hypermethylation of a wide variety of gene promoters
belonging to genes which have been associated with ageing/longevity (Hunter et al., 2012; Scott
et al., 2010). Thus, intrinsic ageing would appear to have an effect on the molecular dynamics of
DNA methylation. This dynamic process is underpinned by several enzymes (Robertson, 2001).
For instance, post replicatively, new CpG sites are attached to the complementary strand of the30
daughter cells, which are unmethylated. DNA methyltransferase (DNMT1) then uses S−Adenosyl
methionine as a substrate to transfer methyl groups to the DNA molecule (Crider et al., 2012). As
DNMT1 preferentially acts on hemimethylated DNA it is widely accepted as primarily a main-
tenance enzyme (Robertson et al., 1999). Consequently, additional enzymes are required for de
novo DNA methylation. It is generally regarded that DNMT3a and DNMT3b are the enzymes35
responsible for this role. In addition to maintenance and de novo methylation, the DNA methyla-
tion cycle is counterbalanced by active and passive demethylation (Chen and Riggs, 2011). Passive
demethylation usually takes place during replication and it is known that methylation levels can
drop following several rounds of replication (Razin and Riggs, 1980). Conversely active methyla-
tion is thought to involve Ten-eleven Translocation (TET ) dioxygenases, which oxidize the methyl40
groups of cytosine; a process which eventually culminates with the reintroduction of an unmethy-
lated cytosine into the DNA molecule (Scourzic et al., 2015). Thus, DNA methylation status is the
combined result of the complex interactions between maintenance/de novo methylation and pas-
sive/active demethylation. Moreover, it can be reasonably argued that the dysregulation of these
processes have a role to play in the onset of aberrant gene promoter methylation and unravelling45
the factors which lead to this dysregulation is of fundamental importance to our understanding of
healthspan and ageing.
Mathematical models have been a key to exploring the intricacies of DNA methylation status
and its intersection with health (reviewed in Mc Auley et al. 2016). Early attempts to capture
mathematically the variability associated with DNA methylation levels are grounded in the re-50
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duced probabilistic mathematical representation of methylation dynamics (known as the standard/
classical model) as proposed by Pfeifer et al. (1990) and further utilised by Riggs and Xiong (2004).
More recently Jeltsch and Jurkowska (2014) extended this mathematical framework by introduc-
ing a term to represent the efficiency of maintenance methylation. In addition to this approach
Haerter et al. (2013) also provided a probabilistic view of DNA methylation by using the Gillespie55
algorithm (Gillespie, 1976) to represent this system. Their model attempted to account for ex-
perimental data which has consistently shown non-random patterns of DNA methylation in CpG
clusters, namely CpG clusters can be hypo-methylated or highly methylated (Illingworth and Bird,
2009). Based on the idea that DNA methylation levels strongly depend on the density of the CpG
cluster, Loevkvist and colleagues attempted to mathematically capture the observed bistability in60
DNA methylation patterns of CpG clusters. Therefore, the explicit assumption was made that
spatial dependent collaboration between CpG sites occurs. In particular, this idea was supported
by the hypothesis that methylated CpG sites are able to recruit methylation enzymes that act on
the CpG sites in the neighbouring area (Dodd et al., 2007). Moreover the assumption was made
that unmethylated CpGs can recruit demethylation enzymes which predispose neighbouring CpGs65
to demethylation in that particular region (Loevkvist et al., 2016).
Methylation bistability of gene promoters is a key area of investigation with this work, as we:
(i) describe the construction and examination of a deterministic model of DNA methylation, (ii)
introduce a mathematical approach for representing a model of DNA methylation, (iii) outline
the reasons why our model provides a more complete representation of the dynamics of DNA70
methylation and (iv) discuss the implications of the findings for our understanding of health and
ageing.
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2. Models and Methods
2.1. Existing Mathematical Models of DNA Methylation Dynamics.
Recently, McGovern and colleagues created a deterministic set of six homogeneous ordinary dif-75
ferential equations, introducing the incorporation of hydroxymethylation by the Ten-eleven Translo-
cation (TET ) enzymes (Scourzic et al., 2015). The authors considered six different states of a
CpG dyad which were represented as follows: 1. unmethylated/unmethylated, 2. unmethylat-
ed/methylated, 3. methylated/methylated, 4. hydroxymethylated/methylated, 5. hydroxymethy-
lated/hydroxymethylated, 6. hydroxymethylated/unmethylated. Mathematically each state was80
represented by x1(t), x2(t), x3(t), x4(t), x5(t) and x6(t), respectively. The rates of the transitions
between the possible states of the CpG dyads were in turn represented by the rate constants kj ,
j = 1 . . . 6. The authors also included the cell division rate d and the rate of cell loss l due to cell
death in their model. The model is represented by the following set of differential equations.
dx1(t)
dt
= (d− l − k1)x1(t) + dx2(t) + dx6(t)
dx2(t)
dt
= k1x1(t)− (l + k2 + k3)x2(t) + 2dx3(t) + dx4(t)
dx3(t)
dt
= k2x2(t)− (d+ l + k4)x3(t)
dx4(t)
dt
= k4x3(t)− (d+ l + k5)x4(t)
dx5(t)
dt
= k5x4(t)− (d+ l)x5(t)
dx6(t)
dt
= k3x2(t) + dx4(t) + 2dx5(t)− lx6(t).
This model was applied to the global methylome and then to local epigenetic regions. Their85
model was able to predict the relative abundances of unmethylated, hemimethylated, fully methy-
lated and hydroxymethylated CpG dyads in the DNA of cells.
Following the work of McGovern et al, Jeltsch and Jurkowska also focused on methylation
dynamics and constructed a single ordinary differential equation, which was based on a classic
model by Pfeifer et al (1990). This model included the interactions among DNMT1, DNMT3a90
and DNMT3b. In addition they included hydroxymethylation by the TET protein family enzymes
as the first step for active demethylation. The authors monitored the evolution of the fraction of
5
methylation at a random CpG site θim(t). They considered methylation (r
i
met) and demethylation
(ridemet) rates, division rate (D) and efficiency of maintenance methylation as a fraction (f
i
main).
However the authors did not dynamically simulate their model.95
dθim(t)
dt
= rimet
(
1− θim(t)
)− (1
2
D(1− f imain) + ridemet)
)
θim(t).
Although both of the preceding models are noteworthy additions to this field in our opinion, it
is necessary to outline some of their limitations. For instance, McGovern and colleagues created a
set of homogeneous, linear ordinary differential equations. The main drawback with systems of this
form is that they produce only trivial equilibrium points. In other words, only the start of the axis
can be a steady state solution of the system, that is, all coordinates equal to zero. This is biologically100
unreasonable because it would mean that the only stable state of the system happens when there
are no CpG dyads of any state in the region of investigation. On the other hand, the Jeltsch
and Jurkowska model calculates the fraction of CpG sites and not CpG dyads. This restricts the
elucidation of the mechanisms underlying locus-specific DNA methylation. For example, DNMT1
shows affinity for hemimethylated CpG dyads, being responsible for maintenance DNA methylation105
(1). As a consequence this mechanism cannot be supported by this model.
2.2. A Linear Model of DNA Methylation
In order to address these specific limitations we created a new mathematical model. This
model retains key elements of both previous models (McGovern et al., 2012; Jeltsch and Jurkowska,
2014). Significantly, however, we introduce three different types of molecules or chemical species of110
interest; unmethylated CpG dyads, hemimethylated CpG dyads and methylated CpG dyads. An
unmethylated CpG dyad is a CpG dyad with none of the two CpG sites methylated. Analogously,
a hemimethylated CpG dyad has only one methylated CpG site and the opposing unmethylated
and a methylated CpG dyad has both opposing sites methylated, see Figure 1. The number of
unmethylated, hemimethylated and methylated CpG dyads is denoted as x1(t), x2(t) and x3(t),115
respectively. Transitions between the possible states of CpG dyads occur due to the methyla-
tion enzymes DNMT1, DNMT3a and DNMT3b, demethylation enzymes TET family and DNA
replication. k1 is the methylation rate of unmethylated CpG dyads, k2 the methylation rate of
hemimethylated CpG dyads, k3 the demethylation rate of hemimethylated CpG dyads, and k4 is
rate of DNA demethylation of methylated CpG dyads and D is the rate of cell division, see also120
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the diagram in Figure 2. For instance, the constant k1 represents the rate that a methyl group
is attached to one of the two opposing CpG sites of an unmethylated CpG dyad (x1) to form a
hemimethylated CpG dyad (x2). All rate constants are defined analogously.
methylated CpG dyad (x3)
hemimethylated CpG dyad (x2)
unmethylated CpG dyad (x1)
Figure 1: The three different states of a CpG dyad; unmethylated (x1), hemimethylated (x2) and methylated (x3)
CpG dyads. A white circle denotes an unmethylated CpG site whereas a black circle represents a methylated CpG
site. An unmethylated (x1) CpG dyad consists of two unmethylated opposite CpG sites, a hemimethylated dyad
(x2) has only one of the two sites methylated and a methylated dyad (x3) has both opposing sites methylated.
As suggested experimentally interactions among the methylation enzymes DNMT1, DNMT3a
and DNMT3b are considered important for maintenance methylation. Rates k3 and k4 are nec-125
essary to represent active demethylation. Mechanistically this is thought to occur by the TET
enzymes hydroxymethylating the cytosine of the CpG sites and eventually reintroducing an un-
methylated cytosine into them (Rasmussen and Helin, 2016). Thus, we consider the process of
hydroxymethylation to be an important intermediate step leading to the active demethylation of a
CpG site.130
x1 x2 x3
k1 k2
k3 k4
D D
Figure 2: Methylation rates between x1, x2 and x3.
During DNA replication, unmethylated DNA strands bond with the parental strands. Thus,
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all methylated CpG dyads of the parental cell produce hemimethylated CpG dyads in the daugh-
ter cells (Waterland and Michels, 2007). The hemimethylated parental CpG dyads either become
unmethylated, or remain hemimethylated in the daughter cells. Unmethylated dyads remain un-
methylated, as outlined in Figure 3.135
If the above processes are translated as a set of ordinary differential equations (ODEs), then
the following system of ODEs is derived
dx1(t)
dt
= −k1x1(t) +
(
k3 +
1
2
D
)
x2(t)
dx2(t)
dt
= k1x1(t)−
(
k2 + k3 +
1
2
D
)
x2(t) +
(
k4 +D
)
x3(t)
dx3(t)
dt
= k2x2(t)−
(
k4 +D
)
x3(t).
(2.1)
The assumption was made that after replication half of the parental hemimethylated CpG dyads
become unmethylated in the daughter cells and the other half remain hemimethylated. Thus, there
is a 12 coefficient in the terms
1
2Dx2(t).140
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parental cell
daughter cell
daughter cell
newly synthesized strands
daughter cell
DNMT1
daughter cell
DNMT1
Figure 3: DNA replication and DNA maintenance methylation. Top left: A parental cell with specific methylation
levels. Top right: DNA replication. New unmethylated CpG sites attach, synthesizing complementary strands
and creating two daughter cells. Bottom left: DNMT1 is responsible for maintaining the methylation levels of the
daughter cells. Bottom right: DNMT1 catalyzes the transfer of methyl groups to the unmethylated CpG sites.
Perturbations to the methylation levels of a variety of gene promoters have been associated
with several diseases and ageing (Gopalakrishnan et al.,2008; Jung and Pfeifer, 2015). Therefore,
our underlying aim with the proposed model (2.1) is to use it to elucidate the dynamics associated
with gene promoter methylation. Moreover, as we are interested in the evolution of a population of
CpG sites in a specific region of the genome with fixed length, the total number of CpG dyads has
to be constant. Thus, we consider x1(t) + x2(t) + x3(t) = C, with C > 0. Regardless of the level of
methylation in the region of interest, the total number of CpG dyads is determined to be C. The
importance of the above relation is that it reduces the size of the set of differential equations by one
and leads to a non-homogeneous linear system. Significantly, its solution stabilizes each time to a
non trivial equilibrium point, which is biologically consistent since the populations xi(t), i = 1, 2, 3
denote the number of CpG dyads and thus they should remain positive. Substituting the above
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equation into the system (2.1), we deduce the equivalent non-homogeneous system
dx1(t)
dt
= −
(
k1 + k3 +
1
2
D
)
x1(t)−
(
k3 +
1
2
D
)
x3(t) + C
(
k3 +
1
2
D
)
dx3(t)
dt
= −k2x1(t)−
(
k2 + k4 +D
)
x3(t) + Ck2
x2(t) = C − x1(t)− x3(t),
(2.2)
which has non-trivial (non-zero) equilibrium solutions.
Gene promoters are differently methylated within the global genome. Indeed, methylation levels
in gene promoters depend on the specific type of tissue under consideration (Lokk et al., 2014). It is
likely however, that methylation mechanisms, on the contrary, are the same for every CpG island,
following the same processes. Thus, it is possible to use our model to quantify the methylation level145
of a specific CpG island. In the first instance, we apply our model to determine methylation levels in
a gene promoter. For that purpose we initially adopt the parameter values suggested by McGovern
et al. Hence, k1 = 0.012D, k2 = 99D, k3 = 0.11D, k4 = 0.08D, is used for calculating methylation
levels in gene promoters, and k1 = 0.205D, k2 = 99D, k3 = 0.04D, k4 = 0.08D, for estimating the
global genome methylation levels. Note that in McGovern’s model, the rates k3 and k4 denote the150
hydroxymethylation of hemimethylated and methylated dyads respectively. This meant that the
same parameter values for active demethylation could be adopted because hydroxymethylation is
the first step of the process that leads to active demethylation. The cell division rate is represented
by D.
Although the linear model gives biologically satisfactory solutions, it cannot predict possible155
changes in the methylation levels due to the onset of disease or ageing. Experimental data sug-
gest DNMT1, which is the enzyme primarily responsible for maintaining DNA methylation levels
following cell replication, suffers from a decrease in activity during ageing (Li et al., 2010). Conse-
quently it can be assumed that the passive demethylation rate increases. It can also be argued this
increase would result in methylation levels in a promoter of a gene in a cancer cell being higher than160
in the same promoter in a healthy cell. Moreover, recent evidence indicates that methylation states
in most average-sized promoters are bistable, namely, they would be either highly methylated or
hypomethylated and hardly ever in an intermediate state (Haerter et al., 2014). For these reasons,
it is reasonable to assume that the transition rates kj are not constant but change with respect to
time.165
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In the current subsection a mathematical model is constructed for predicting potential changes
in methylation levels due to disease and ageing. A reasonable way to accomplish this is by making
the cogent assumption that the methylation rates are functions of the population of CpG dyads,
i.e. kj = kj(xi(t)), i, j = 1, . . . , 4. In particular this approach illuminates how de novo methylation,
maintenance methylation and active demethylation can possibly change over time. The majority170
of gene promoters are either in a hypomethylated or in a highly methylated state. In the former
state, the majority of the CpG dyads are unmethylated, whilst it has been experimentally found
that when CpG dyads are in a highly methylated state, the majority of the CpG dyads are occupied
with methyl groups (Haerter et al., 2014). In order to describe a possible transition between the two
states it is necessary to appreciate the following biological arguments. If a scenario exists whereby175
there is an abundance of unmethylated CpG dyads (x1) and the gene promoter is hypomethylated.
It is then biologically plausible that with time unmethylated CpG dyads start to become methylated.
This could happen due to fluctuating levels ofDNMT3a andDNMT3b (denoted in the model by an
increase in k1 rate). As the number of unmethylated CpG dyads (x1) drops, the methylation rate k1
increases. While the number of unmethylated dyads decreases, then the number of hemimethylated180
dyads (x2) increases. This can be interpreted as k1 being a decreasing function of x1(t) or an
increasing function of x2(t). It is not known if the transition between the two different states is
either due to a rise in de novo methylation enzymes (DNMT3a and DNMT3b) or because of a
decrease in the active demethylation enzymes (TET protein family). To describe the latter, we
can assume the similar argument, that as the number of unmethylated CpG dyads (x1) decreases,185
the demethylation rate k3 drops, due to the decrease in the TET enzymes and consequently the
number of hemimethylated CpG dyads increases. This can be interpreted as denoting the k3 rate
as an increasing function of x1(t) or a decreasing function of x2(t). The exact same argument can
be stated for the transition rates k2 and k4. A huge increase in methylated CpG dyads can be a
result of either an increase in DNMT1 maintenance levels or a decrease in TET enzymes, namely190
either a k2 increase or a k4 drop. Therefore, k2 can be a decreasing function of x2 or an increasing
function of x3 and k4 an increasing function of x2 or a decreasing function of x3.
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Table 1: Transition rates kij are functions of populations of CpG dyads, x1, x2 and x3. There are two different
function selections that comply with the biological evidence. The arrow next to each formula denotes an increasing
or decreasing function of xi. All parameters kij are positive.
Selection I
kj functions of x1,x3
k1(x1) = k11 − k12x21 (↘)
k2(x3) = k21 + k22x
2
3 (↗)
k3(x1) = k31 + k32x
2
1 (↗)
k4(x3) = k41 − k42x23 (↘)
Selection II
kj functions of x2
k1(x2) = k11 + k12x
2
2 (↗)
k2(x2) = k21 − k22x22 (↘)
k3(x2) = k31 − k32x22 (↘)
k4(x2) = k41 + k42x
2
2 (↗)
Following this rationale, two different mathematical formulae are introduced to account for the
transition rate functions, (see Table 2).]A nonlinear model describing gene promoter bistability.
Although the linear model gives biologically satisfactory solutions, it cannot predict possible195
changes in the methylation levels due to the onset of disease or ageing. Experimental data sug-
gest DNMT1, which is the enzyme primarily responsible for maintaining DNA methylation levels
following cell replication, suffers from a decrease in activity during ageing (Li et al., 2010). Conse-
quently it can be assumed that the passive demethylation rate increases. It can also be argued this
increase would result in methylation levels in a promoter of a gene in a cancer cell being higher than200
in the same promoter in a healthy cell. Moreover, recent evidence indicates that methylation states
in most average-sized promoters are bistable, namely, they would be either highly methylated or
hypomethylated and hardly ever in an intermediate state (Haerter et al., 2014). For these reasons,
it is reasonable to assume that the transition rates kj are not constant but change with respect to
time.205
In the current subsection a mathematical model is constructed for predicting potential changes
in methylation levels due to disease and ageing. A reasonable way to accomplish this is by making
the cogent assumption that the methylation rates are functions of the population of CpG dyads,
i.e. kj = kj(xi(t)), i, j = 1, . . . , 4. In particular this approach illuminates how de novo methylation,
maintenance methylation and active demethylation can possibly change over time. The majority210
of gene promoters are either in a hypomethylated or in a highly methylated state. In the former
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state, the majority of the CpG dyads are unmethylated, whilst it has been experimentally found
that when CpG dyads are in a highly methylated state, the majority of the CpG dyads are occupied
with methyl groups (Haerter et al., 2014). In order to describe a possible transition between the two
states it is necessary to appreciate the following biological arguments. If a scenario exists whereby215
there is an abundance of unmethylated CpG dyads (x1) and the gene promoter is hypomethylated.
It is then biologically plausible that with time unmethylated CpG dyads start to become methylated.
This could happen due to fluctuating levels ofDNMT3a andDNMT3b (denoted in the model by an
increase in k1 rate). As the number of unmethylated CpG dyads (x1) drops, the methylation rate k1
increases. While the number of unmethylated dyads decreases, then the number of hemimethylated220
dyads (x2) increases. This can be interpreted as k1 being a decreasing function of x1(t) or an
increasing function of x2(t). It is not known if the transition between the two different states is
either due to a rise in de novo methylation enzymes (DNMT3a and DNMT3b) or because of a
decrease in the active demethylation enzymes (TET protein family). To describe the latter, we
can assume the similar argument, that as the number of unmethylated CpG dyads (x1) decreases,225
the demethylation rate k3 drops, due to the decrease in the TET enzymes and consequently the
number of hemimethylated CpG dyads increases. This can be interpreted as denoting the k3 rate
as an increasing function of x1(t) or a decreasing function of x2(t). The exact same argument can
be stated for the transition rates k2 and k4. A huge increase in methylated CpG dyads can be a
result of either an increase in DNMT1 maintenance levels or a decrease in TET enzymes, namely230
either a k2 increase or a k4 drop. Therefore, k2 can be a decreasing function of x2 or an increasing
function of x3 and k4 an increasing function of x2 or a decreasing function of x3.
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Table 2: Transition rates kij are functions of populations of CpG dyads, x1, x2 and x3. There are two different
function selections that comply with the biological evidence. The arrow next to each formula denotes an increasing
or decreasing function of xi. All parameters kij are positive.
Selection I
kj functions of x1,x3
k1(x1) = k11 − k12x21 (↘)
k2(x3) = k21 + k22x
2
3 (↗)
k3(x1) = k31 + k32x
2
1 (↗)
k4(x3) = k41 − k42x23 (↘)
Selection II
kj functions of x2
k1(x2) = k11 + k12x
2
2 (↗)
k2(x2) = k21 − k22x22 (↘)
k3(x2) = k31 − k32x22 (↘)
k4(x2) = k41 + k42x
2
2 (↗)
Following this rationale, two different mathematical formulae are introduced to account for the
transition rate functions, (see Table 2). The arrow next to each formula denotes an increasing or
decreasing function of xi. These reactions are akin to second order kinetics which are common235
in biochemical systems. Both selections for the transition rates were used to obtain the nonlinear
system. The nonlinear system corresponding to the selection II transition rates was only able
to predict one global equilibrium point for the CpG populations, thus leaving us with the same
limitation as the linear system. Therefore, if Selection I is selected, we obtain the following nonlinear
system240
dx1(t)
dt
= −A1(x1(t))x1(t)−A2(x1(t))x3(t) +A3(x1(t))C
dx3(t)
dt
= −B1(x3(t))x1(t)−B2(x3(t))x3(t) +B3(x3(t))C
x2(t) = C − x1(t)− x3(t),
(2.3)
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where
A1(x1(t)) = k11 − k12x21(t) + k31 + k32x21(t) +
1
2
D,
A2(x1(t)) = k31 + k32x
2
1(t) +
1
2
D,
A3(x1(t)) = k31 + k32x
2
1(t) +
1
2
D,
B1(x3(t)) = k21 + k22x
2
3(t),
B2(x3(t)) = k21 + k22x
2
3(t) + k41 − k42x23(t) +D,
B3(x3(t)) = k21 + k22x
2
3(t).
The specific selection of the rate functions k2 and k3, is inspired by biological mechanisms and as
it is shown below, leads to the bistability which has been observed experimentally in CpG clusters
(Haerter et al., 2014). In particular, it has been suggested that due to the interaction between
neighbouring CpG sites, methylated CpG sites affect the methylation status of nearby unmethylated245
sites; hence the rate of methylation k2 increases as the population of methylated dyads x3 grows.
Conversely, an abundance of unmethylated CpG sites in a CpG cluster influences the demethylation
of close methylated sites; thus, the demethylation rate k3 increases while unmethylated CpG dyads
x1 increase. In addition, if we consider that intrinsic ageing has the potential to dysregulate
DNMT1 this will result in a decrease in global methylation levels. In other words, a drop in the250
value of k2 results in a concomitant drop in globally methylated CpG dyads x3. Both functions k2
and k3, therefore, are described in terms of x3 and x1, respectively. The same argument can be
stated as a reasonable reasoning for the selection of the rate functions k1 and k4. In both cases,
a decrease in DNMT3a and DNMT3b results primarily in an abundance of unmethylated CpG
dyads x1, so k1 would be more appropriately denoted as a decreasing function of x1. The same255
arguments are valid for k4 as well.
The analysis of the nonlinear model (2.3) was done by using Matlab 2017a. For the delivered
simulations a specific interval of values was determined for each transition rate function kj so that
the model predicts the observed bistability of gene promoters. For that purpose and for a CpG
cluster of a hundred CpG dyads size, i.e. C = 100, transition rate functions were selected in the260
following intervals, 1.9 ≤ k1 ≤ 2.1, 10 ≤ k2 ≤ 110, 1 ≤ k3 ≤ 100 and 2 ≤ k4 ≤ 4. In order to
determine the values of the parameters, the expression of each rate function was substituted into
the intervals. As a result the values listed in Table 3 were determined.
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Table 3: Nonlinear model parameter values
k11 k12 k21 k22 k31 k32 k41 k42
2.1 2× 10−5 10 10−2 1 10−2 4 2× 10−4
3. Results and discussion
Mathematical analysis was conducted for both the linear and the nonlinear model. Equilibrium265
points were calculated for the linear system and stability analysis for both of the systems was
delivered by constructing the phase plane portraits which provide graphically a representation of
the solutions. In addition sensitivity analysis was performed to assess the impact of parameter
perturbations. Matlab 2017a was used for producing the phase plane portraits and for performing
the sensitivity analysis for parameters for the nonlinear model.270
3.1. Linear model outcomes
We examined the equilibrium state of the system x(t) = (x1(t), x2(t), x3(t))
T ; namely, the
equilibrium point of the system was calculated when the condition ddtx(t) = 0 is solved. We then
obtained the following expression for the equilibrium point with respect to the parameters
xss1 =
C(2k3 +D)(D + k4)
D(2k1 + 2k3 + k4) + 2(k1k2 + k1k4 + k3k4) +D2
,
xss2 =
2k1D + 2k1k4
D(2k1 + 2k3 + k4) + 2(k1k2 + k1k4 + k3k4) +D2
,
xss3 =
2Ck1k2
D(2k1 + 2k3 + k4) + 2(k1k2 + k1k4 + k3k4) +D2
.
Mathematical analysis showed that all three components of the equilibrium point are always275
positive and less than C = 100, for any positive values of the parameters. In addition, stability anal-
ysis indicated that the equilibrium point is stable for all positive selection of the parameter values.
The latter actually entails that in a region of investigation, like a CpG island, our model predicts
that no matter what the initial methylation levels are, the number of unmethylated, hemimethy-
lated and methylated CpG dyads will always converge to a steady-state value inside the interval280
[0, 100].
In order to examine the model in a specific region of the genome, it would be necessary to
have clear experimental data. In the absence of experimental data, the assumption that we were
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working with a promoter of a gene was made. Data suggests that the values of the parameters
should be considered as in the McGovern et al. paper (McGovern et al., 2012) for local epigenetic285
regions. Thus, k1 = 0.012D, k2 = 99D, k3 = 0.11D, k4 = 0.08D,D = 1 and C = 100. were
selected. As shown in Figure 4, our model predicts that the equilibrium methylation state for
this promoter would be: 38.2% unmethylated, 0.8% hemimethylated and 61% methylated CpG
dyads. The fact the equilibrium point is stable ensures the heredity of post replicative maintenance
methylation. Moreover, any perturbation in the availability of DNMT1, DMNT3a,DNMT3b290
or the TET family enzymes during methylation or active demethylation is temporary and will
eventually terminate. Therefore, the linear model accounts for the overall epigenetic inheritance of
DNA methylation patterns and dynamics.
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x1 ' = - (k1 + k3 + 1/2 D) x1 - (k3 + 1/2 D) x3 + C (k3 + 1/2 D)
x3 ' = - k2 x1 - (k2 + k4 + D) x3 + C k2                        
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Figure 4: Phase plane portrait of solutions for the linear model (2.2). The above figure shows the percentage
of unmethylated CpG dyads versus the unmethylated CpG dyads. For k1 = 0.012D, k2 = 99D, k3 = 0.11D,
k4 = 0.22D,D = 1 and C = 100, the equilibrium point is (x1, x3) = (38.2, 61).
3.2. Nonlinear model outcomes
The nonlinear model (2.3) was created to overcome some significant weaknesses of the linear295
model. Due to the presence of the nonlinear terms we had to use numerical methods to solve it.
The 4th order Runge-Kutta method was implemented for defining the equilibrium points of the
system, and for performing sensitivity analysis for the parameters perturbation.
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Figure 5: Transition rate functions kj versus populations xi for a CpG cluster of C = 100 CpG dyads in total.
k1(x1) = k11 − k12x21, k2(x3) = k21 + k22x23, k3(x1) = k31 + k32x21 and k4(x3) = k41 − k42x23. with k11 = 2.1,
k12 = 2 × 10−5, k21 = 10, k22 = 10−2, k31 = 1, k32 = 10−2, k41 = 4, k42 = 2 × 10−4.
3.2.1. Nonlinear Phase Plane Portrait
Notably the transition rates are not constants anymore but vary over time. We selected rates300
as functions of population of CpG dyads, namely k1(x1) = k11 − k12x21, k2(x3) = k21 + k22x23,
k3(x1) = k31 + k32x
2
1 and k4(x3) = k41 − k42x23, (see Figure 5).
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For computational purposes and for the reasons explained in the previous section, we focus on
the case of a gene promoter of C = 100 CpG dyads length, for which experimental evidence suggests
that the following parameters k11 = 2.1, k12 = 2×10−5, k21 = 10, k22 = 10−2, k31 = 1, k32 = 10−2,305
k41 = 4, k42 = 2 × 10−4 should be considered. Then the model produces two stable equilibrium
points (x1, x2, x3) = (2.2, 3.1, 94.7) and (x1, x2, x3) = (93.9, 2, 4.1), see Figure 6. This means that
there are two possible scenarios regarding the eventual methylation level of the promoter. In the
first case the promoter is hypermethylated, as the first equilibrium point dictates, with 94.7% of
the total CpG dyads within the promoter being methylated, and only 2.2% remain unmethylated.310
The second scenario corresponds to the promoter being in a hypomethylated state, with only 4.1%
of the total CpG dyads methylated and 93.9% unmethylated. Therefore it could be reasonably
inferred that the first scenario represents the hypermethylation of the promoter, possibly due to
ageing. The promoter we consider was assumed to be a generic promoter akin to a homebox gene. If
the gene is responsible for suppressing genetic mutations in the cell, its silencing would potentially315
lead to cancer development. Depending on the gene function, silencing due to hypermethylation
could potentially lead to different diseases. Analogously, the second case represents the normal
hypomethylated state of the promoter, where the gene is active. There is an intermediate region
which separates these two stable regions. This region denotes a methylation state threshold where
if exceeded, methylation levels change properly in the promoter.320
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x1 ' = - (k11 - k12 x12) x1 + (k31 + k32 x12 + 1/2) (100 - x1 - x3)  
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Figure 6: Phase plane portrait for the solutions of the nonlinear model (2.3). The above figure shows the percentage of
unmethylated CpG dyads versus the unmethylated CpG dyads. Assuming that k11 = 2.1, k12 = 2× 10−5, k21 = 10,
k22 = 10−2, k31 = 1, k32 = 10−2, k41 = 4, k42 = 2×10−4, two stable equilibrium points occur; (x1, x3) = (2.2, 94.7)
and (x1, x3) = (93.9, 4.1).
3.2.2. Sensitivity analysis
A sensitivity analysis for the parameters of the system was performed. This approach allowed us
to identify how a variation in the value of the parameters of the model would influence the solution
of the system. In other words, we used a sensitivity analysis to examine how a possible change in
the availability of the methylation and demethylation enzymes would affect the methylation levels325
and the dynamics of the model under investigation. For that purpose we increased the parameters
by 5%, 10%, 25%, 50%, 100% and decreased them by 5%, 10%, 25%, 50%, 75%. Next we calculated
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Table 4: Sensitivity analysis for the parameters of the nonlinear model (2.3). Each parameter was increased by
50%. The percentage change was calculated for each variable of the system. Parameters k11 and k32 had the most
significant impact on both hemimethylated and methylated CpG dyads whereas k21 and k41 cause a noticeable
change in methylated dyads.
50% change in parameter % change in x1 % change in x2 % change in x3
k11 4.2 61.7 64.7
k12 0.3 4.9 5
k21 2.4 3.1 54.4
k22 0.04 0.3 0.9
k31 0.04 0.8 0.6
k32 2.3 34.8 34.4
k41 1.3 1.8 29.8
k42 0.001 0.2 0.04
the percentage change in the solution for x1, x2 and x3 and the results are presented in Table 4.
After ranking the results, we calculated the Spearman’s rank correlation coefficient, usually called
Spearman’s r.330
The rankings between the various increases and decreases in parameters are compared for each
variable, xi. It is found that the order of the impact of parameters on x2 and x3 between 5%
increases and 100% increases was exactly the same, see Table 5. This confirmed that none of the
parameters of the system has a switching on effect, that is, when they reach at a particular threshold,
their effect on the system is greatly increased, in relation to the other parameters. Having identified335
this, it is inferred that the DNA methylation mechanisms remained unaltered despite changes to
the parameters. For example, the sensitivity analysis shows that a change in the quantity of the de
novo methylation enzymes DNMT3a and DNMT3b causes a significant change in the number of
hemimethylated and methylated CpG dyads, but not in the unmethylated dyads. The Spearman’s
rank analysis also indicates that hemimethylated and methylated dyads are more sensitive to a340
DNMT3a and DNMT3b change compared to the unmethylated ones.
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Table 5: The Spearman’s rank correlation coefficient r calculated indicates a positive correlation for r = 1 and no
correlation for r = 0.
x1 x2 x3
Spearman’s r 0.987 1 1
In order to explore the mechanics of DNA methylation further, we compare all xi rankings to
identify a correlation between them. Interestingly, comparing x1 rankings with x3 rankings yielded
a positive correlation, i.e. r = 1. This means that the parameters of the nonlinear system (2.3)
affect x1 and x3 with the same order of magnitude. In addition, both x1 rankings compared to345
x2 and x2 rankings compared to x3 yield a significant correlation, r = 0.89. Generally, changes in
the quantity of the enzymes taking part in the DNA methylation processes cause changes in the
number of the three different states of CpG dyads with the same order of magnitude.
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4. Conclusion
Based on the biological assumptions made in pre-existing models in the literature, two mathe-350
matical models were constructed; the linear model (2.2) and the nonlinear one (2.3). Both models
were built to address mathematical and biological limitations of the pre-existing models. Our key
idea based on the fact that the total number of CpG dyads in a region of investigation is always
constant. The linear model (2.2) demonstrated the methylation levels in any region of the genome,
from CpG islands, to the whole genome. Each transition rate kj was considered constant over time.355
The linear model, however, was unable to predict possible changes in methylation levels caused by
perturbations in the enzymes taking part in the methylation processes. In order to address this
limitation we constructed the nonlinear model (2.3). Transition rates, for the latter model, were
considered as functions of populations xi and thus varied over time. The outcomes of the nonlinear
model are in agreement with experimental work, namely, the observed bistable methylation states360
found in gene promoters can be predicted.
As the existing models (McGovern et al., 2012) (Jeltsch & Jurkowska, 2014), both linear
and nonlinear model were constructed considering continuous and deterministic dynamics. The
advantage of the assumption that the transition rates vary over time is that the obtained nonlinear
system possesses two stable equilibrium points, each one representing a stability state of methylation365
in the region of investigation. Past models were only able to attribute a single - sometimes trivial -
equilibrium point, failing to portray the potentiality of change in methylation levels of CpG islands.
Furthermore, McGovern and colleagues introduced the incorporation of hydroxymethylation by the
Ten-eleven Translocation (TET ) enzymes; we considered active demethylation rates instead, to
account for the action of TET enzymes. In addition, another key difference between our nonlinear370
model and the model by Jeltsch & Jurkowska is the consideration of CpG dyads as the variables of
our system, in contrast to the proposal of regarding CpG sites as the main variables in their work.
In our opinion, investigating the methylation levels in CpG dyads provides a better understanding
of the processes underlying DNA methylation; Moreover, we were able to dynamically simulate our
model, mathematically analyze the stability of the equilibrium points and examine the sensitivity375
of the parameters of the system.
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Additionally, one of the key predictions of our model it that DNA methylation dynamics do
not alter when the quantity of DNA methylation enzymes changes. A worthwhile way to test the
validity of this prediction would be to perform methylation assays using the three methylation en-
zymes, DNMT1, DNMT3a and DNMT3b. In fact methylation assays for each of these enzymes380
have been identified (Poh et al., 2016). It would be relatively straightforward from an experimental
standpoint to design an investigation which quantifies DNA methylation levels based on the differ-
ent cellular concentration of each enzyme or to design an experiment which measures the level of
DNA methylation in response to varying concentrations of different combinations of these enzymes.
This experiment could be enriched further if conducted in tandem with a gene promoter whereby385
bistability has been observed. For instance, there is an array of genomic regions which display this
phenomenon (Zhang et al., 2009)
Although, our nonlinear model (2.3) provides new insights into the dynamics of DNA methy-
lation dynamics, it is important to recognize that it has a number of limitations that need to be
addressed. Notably intrinsic and extrinsic noise are acknowledged factors intracellularly. Therefore,390
a deterministic model, as (2.3), can predict up to a level of certainty the levels of methylation by
calculating the values of the variables of the system at any given time. Thus, uncertainty could be
introduced in the model to describe the presence of intrinsic and extrinsic noise. This way it would
be possible for models to account for the stochastic nature in cell dynamics. In addition, continuous
and deterministic models are very convenient to construct, but they have limitations for biological395
processes and specifically for DNA methylation dynamics. In this work we considered cell division
as a continuous process occurring over time although it only occurs in discrete time steps.
Moreover, it is possible to expand our model to include additional biological mechanisms.
Firstly, a worthwhile addition to the model would be to incorporate the functional forms which
describe the enzymatic reactions underpinning the rate laws in our model. For instance, the math-400
ematics which characterize the enzymatic mechanism of action of DNMT1 have previously been
proposed (Svedruzic, 2008). Secondly, we propose including the dynamics of folate cycle in our
model, as ultimately the folate cycle is the source of the methyl groups which attach to the DNA
molecule. Several ODE models of the folate cycle have been built previously and scope exists for
connecting our model to these (Sora and Mc Auley, 2016; Duncan et al., 2013; Nijhout et al., 2004;405
Reed et al., 2006).
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